Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Statera Biopharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 33 | +5 |
| Shares | 2.03M | 1.38K | 2.13M | +102.8K (+5.1%) |
| Value | $4.64M | $3.00K | $669.2K | −$3.97M (−85.6%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Statera Biopharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empery Asset Management, LP | 333,016 | $105.0K | 0.49% |
| UBS Group AG | 118,672 | $37.0K | 0.00% |
| Two Sigma Securities, LLC | 78,189 | $25.0K | 0.00% |
| Two Sigma Investments, LP | 58,519 | $18.0K | 0.00% |
| Citadel Advisors LLC | 20,368 | $7.00K | 0.00% |
| HRT Financial LP | 22,539 | $7.00K | 0.00% |
| Price T Rowe Associates Inc | 11,700 | $4.00K | 0.00% |
| Sandhill Capital Partners LLC | 13,570 | $4.00K | 0.00% |
| Jane Street Group, LLC | 10,761 | $3.00K | 0.00% |
| Tucker Asset Management LLC | 1,000 | $315 | 0.00% |
| Orion Capital Management LLC | 50 | $0 | 0.00% |
| IFP Advisors, Inc | 500 | – | – |
Sold out (7)
Institutions that held Statera Biopharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Potomac Capital Management, Inc. | 381,900 | $878.0K |
| Eaton Vance Management | 154,067 | $354.0K |
| Charles Schwab Investment Management Inc | 12,170 | $28.0K |
| Royal Bank of Canada | 5,000 | $12.0K |
| Simplex Trading, LLC | 3,912 | $8.00K |
| Advisor Group Holdings, Inc. | 365 | $1.00K |
| Accel Wealth Management | 250 | $1.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Statera Biopharma, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 1,381 | $3.00K |